Effects of anticancer drugs on transcription factor-DNA interactions

Area of Science:

• Biochemistry
• Molecular Biology
• Pharmacology

Background:

• DNA-interacting anticancer drugs modulate protein binding through reversible or covalent interactions.
• Understanding these drug-DNA-protein interactions is crucial for developing effective cancer therapies.

Purpose of the Study:

• To review the effects of DNA-interacting anticancer drugs on transcription factor interactions with DNA.
• To classify the mechanisms by which these drugs influence DNA-protein binding.
• To present novel strategies for targeted gene regulation in cancer therapy.

Main Methods:

• Literature review of studies on DNA-interacting anticancer drugs and transcription factor modulation.
• Classification of drug-induced effects on DNA-protein interactions.
• Overview of emerging antigene strategies and sequence-specific binding molecules.

Main Results:

• Drug effects on transcription factor binding include competition, weakening, enhancement via DNA modification, and a 'suicide' mechanism.
• Anticancer drugs can create non-natural binding sites, altering gene regulation.
• New strategies like antigene approaches with oligonucleotides, peptide nucleic acids, and polyamides offer targeted therapeutic potential.

Conclusions:

• DNA-interacting drugs significantly impact transcription factor binding, offering diverse mechanisms for therapeutic intervention.
• Novel approaches like antigene strategies and sequence-specific molecules represent promising avenues for cancer treatment.
• Further research into these drug-DNA-protein interactions can lead to more precise and effective anticancer therapies.